Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.

Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.

Item
http://www.wikidata.org/entity/Q34057328
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody PreparationsA three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A.Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin.A rational approach to enhancing antibody Fc homodimer formation for robust production of antibody mixture in a single cell line.A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A.A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E.
P2860

Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.

Item
http://www.wikidata.org/entity/Q34057328
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@ast
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@en
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@nl
type
label
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@ast
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@en
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@nl
prefLabel
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@ast
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@en
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Safety and pharmacokinetics of ...... ies against botulinum toxin A.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932